AZAndrey V. Zatynko

Andrey V. Zatynko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Andrey V. Zatynko has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • CEREBRAL SMALL VESSEL DISEASE IN YOUNG PATIENTS WITH ISCHEMIC STROKE: PREVALENCE OF MARKERS AND IMPACT ON COGNITIVE OUTCOMES

    by K.V. Rerikh, L.а. Shchepankevich, Ya.L. Manakova, М.S. Ponomareva, А.V. Zatynko, А.а. Ponomarenko, D.а. Michkov

    Introduction. Cerebral small vessel disease (CSVD) is the leading cause of vascular cognitive impairment, accounting for 10–30% of all strokes. Despite the increasing incidence of ischemic stroke (IS) among young adults (under 50 years of age), the prevalence and pattern of CSVD MRI markers, as well as their role in the development of post-stroke cognitive impairment (PSCI) in this age group, remain poorly understood. Aim of the research. To assess the frequency and structure of CSVD markers using the CSVD total burden scale in young patients with ischemic stroke, and to analyze their correlation with cognitive outcomes in the acute and late recovery periods after ischemic stroke. Materials and methods. A prospective observational cohort study was performed, including 78 patients aged 18–50 years with first-time verified ischemic stroke (IS). MRI markers of CSVD (lacunae, white matter hyperintensities according to the Fazekas scale, cerebral microbleeds, dilated perivascular spaces) were assessed using the STRIVE2 criteria with calculation of the total CSVD score (0–4). Cognitive functions were assessed using the MoCA test in the acute period (T0, 3–7 days from IS onset), after 6 months (T6), and 12 months (T12). Patients were divided into two groups: SVD = 0 (n = 34) and SVD ≥ 1 (n = 44). Statistical analysis included two-way analysis of variance with repeated measures (mixed-effects model, REML), post-hoc analysis with correction for multiple comparisons, and correlation analysis. Results. SVD signs (SVD ≥ 1) were detected in 56.41% of patients. The most common marker was dilated perivascular spaces (39.56%), the least common was cerebral microbleeds (12.09%). The most common paired combination was lacunae and perivascular spaces (12.82%). A moderate negative correlation was found between the total SVD score and MoCA scores at all time points (r from -0.44 to -0.57), most pronounced at 12 months (r = -0.57). In the acute period, no significant intergroup differences in MoCA were found (p = 0.1518), however, after 6 months (mean difference -3.868; p = 0.0285) and 12 months (mean difference -4.387; p = 0.0105), patients with SVD ≥ 1 demonstrated significantly lower cognitive scores. The dynamics of cognitive functions was characterized by improvement in both groups over the course of a year (p = 0.0242). Conclusion. More than half of young patients with ischemic stroke have signs of small vessel disease. Dilated perivascular spaces are the most common and potentially early marker of CSVD in this patient population. The presence of CSVD (SVD ≥ 1) is associated with persistent cognitive deficits late after stroke, justifying the need for routine MRI assessment of perivascular dystonia markers to stratify the risk of cognitive impairment and individualize neurorehabilitation programs in young patients.

  • The course of cryptogenic ischemic stroke in young adults with obesity

    by M.S. Ponomareva, L.A. Shchepankevich, K.V. Rerikh, A.V. Zatynko

    Introduction. Ischemic stroke (IS) in young adults, or premature stroke, is becoming increasingly significant due to its rising incidence and the high proportion of patients with unspecified etiology (UE). Obesity, a currently widespread pathology and a key risk factor for cardiovascular diseases, may exacerbate the course of IS. Aim. The assessment of neurological deficit, severity, and the degree of disability in the hyperacute and acute phases of IS of UE, i.e. cryptogenic stroke, in young patients based on the presence or absence of obesity. Materials and methods. The prospective study included two groups of patients with cryptogenic IS, aged 18–50 years: the main group of 34 patients with obesity (body mass index (BMI) >30,0 kg/m2) and the comparison group of 32 patients without obesity (BMI 18,5–24,9 kg/m2). Clinical, anthropometric, and demographic parameters were assessed. Functional status was evaluated using the modified Rankin Scale (mRS), and neurological deficit – using the National Institutes of Health Stroke Scale (NIHSS). Results. The analysis of neurological symptoms in the hyperacute phase of stroke revealed no statistically significant differences between the groups, except for seizure syndrome at the onset, which was observed only in obese patients (11,76%, p = 0,045). The severity of the disease (assessed by the NIHSS) was significantly higher in the obesity group both at admission (7,26 ± 1,62 vs. 5,68 ± 3,89; p = 0,04) and on day 21 ± 5 (2,71 ± 2,1 vs. 1,81 ± 1,35; p = 0,043). However, the early functional outcomes (assessed by the mRS) by day 21 ± 5 showed no significant differences between the groups (1,91 ± 1,4 vs. 1,47 ± 1,2; p = 0,2). Conclusion. Stroke in young obese patients is characterized by a more severe course, likely due to the influence of dysfunctional adipose tissue, which contributes to development of systemic inflammation and metabolic disorders.

  • Open Access

    Metabolic predictors of ischemic stroke in young adults

    by Maria S. Ponomareva, Larisa A. Shchepankevich, Ksenya V. Rerikh, Andrey V. Zatynko, Ksenia V. Antonova, Marine М. Tanashyan, Рерих Ксения Викторовна

    Introduction. Ischemic stroke (IS) has a tendency towards younger age of onset among working-age adults, with an increasing role of obesity in IS development. New prognostic markers affecting stroke severity and early outcomes are being sought. Aim: to investigate etiology and risk factors of cryptogenic IS in working-age patients (18–50 years) and evaluate the significance of metabolic markers of obesity and hemostasis in predicting immediate disease outcomes. Materials and methods. We retrospectively analyzed 343 medical records of acute stroke patients aged 18–50 years using clinical, laboratory, and imaging findings and calculated risk levels. Results. Obesity was observed in more than half (51.3%) of the patients. Early atherosclerotic changes in the vessel wall were detected in 62.26% of the cases. Worse immediate stroke outcomes were associated with all obesity parameters: body mass index (r = 0.48), waist circumference (WC) (r = 0.43), waist-to-hip ratio (WHR) (r = 0.52), levels of glucose (r = 0.47), C-reactive protein (r = 0.34), hematocrit (r = 0.41), high-density lipoproteins (r = –0.32), von Willebrand factor (r = 0.58), fibrinogen (r = 0.66), FVIII (r = 0.50), D-dimer (r = 0.50), and ADP-induced platelet aggregation (r = 0.41). Stroke severity was found to correlate with levels of triglycerides (r = 0.57), low-density lipoproteins (r = 0.35), von Willebrand factor (r = 0.55), fibrinogen (r = 0.46), coagulation factor VIII (r = 0.63), D-dimer (r = 0.39), antithrombin III (r = 0.39), and WHR (r = 0.53). Receiver operating characteristic curves revealed triglyceride-glucose index to be a predictor of worse early outcome (area under the curve, 0.66; threshold, 4.7), including in terms of WC (0.68 and 497.6, respectively) or stroke severity (0.63 and 4.7, respectively). Conclusion. IS in young adults is accompanied by impaired metabolism, affecting the disease outcome. Indices including glucose, triglycerides, and the obesity status can play a role in predicting the stroke severity in young adults, among others.


  • Open Access

    Asthenia and vascular cognitive impairment in young patients after stroke

    by L. A. Shchepankevich, K. V. Rerikh, M. S. Ponomareva, A. V. Zatynko, E. V. Taneeva

    Post-stroke cognitive impairment (PSCI) is found in most patients over 50 years of age. At a young age, PSCI has a negative impact on daily activities, quality of life and return to work, regardless of physical recovery. Often PSCI are combined with asthenia, but there is very little information on the prevalence of post-stroke asthenia (PSA). Currently, the treatment of PSCI and PSA in young patients with citicoline is still controversial.Objective: to evaluate the prevalence of PSCI and PSA in young patients and the efficacy and safety of the domestic drug Noocil (citicoline) in the treatment of PSCI and PSA in stroke patients of young age.Material and methods. The work was conducted in two stages: the first stage was a longitudinal study of cognitive status using neurocognitive scales and assessment of signs of asthenia in patients aged 18 to 45 years; the second stage was an open prospective observational study of 47 patients aged 18 to 45 years with confirmed ischemic stroke (IS) who were randomly assigned to groups with Noocil administration (main group; n=26) or without treatment (control group; n=21). Cognitive function was assessed by Montreal Cognitive Assessment (MoCA) and asthenia by manifestations of general fatigue (Multidimensional Fatigue Inventory, MFI-20).Results. High frequency of PSCI (51%) and the severity of asthenia according to MFI-20 scale were found in the hospital sample of young patients with IS. A direct correlation was found between the severity of PSA and the degree of cognitive decline. The positive effect of Noozil on cognitive functions, emotional state and severity of asthenia in the study group was noted. At the end of treatment, the mean MoCA score was 27.4±1.4 in the main group and 25.9±1.1 in the control group (pConclusion. The high incidence of PSCI and PSA and the positive effect of Noocil on the non-motor consequences of stroke in young patients and the high safety profile of the drug were shown.